Skip to main content

Table 3 Diagnostic performance of biomarkers alone for lung-cancer death

From: Serum and blood based biomarkers for lung cancer screening: a systematic review

Test Evaluated

MSC

miR-test

Sensitivity

95% (95%CI: N/A)

100% (95%CI: N/A)

Specificity

78% (95% CI: 75–80%)

73% (95% CI: 70–76%)

PPV

8% (95% CI: 5–12%)

1.1% (95% CI: N/A)

NPV

99% (95% CI: N/A)

100% (95% CI: N/A)

Positive LR

4.27

3.72